SCAND1

SCAND1 (RAZ1) is a nuclear SCAN domain-containing protein that functions as a protein-interaction module governing the activity of SCAN-zinc finger transcription factors (PMID:10777584, PMID:16540086). Identified as a binding partner of the MZF1B SCAN box, SCAND1 uses its carboxyl-terminal SCAN-related domain to mediate both self-association and heterodimerization with SCAN-domain partners, and the same C-terminal region is sufficient for nuclear localization (PMID:10777584, PMID:12383503). Because SCAND1 lacks zinc finger motifs, its heterodimer with the SCAN-zinc finger protein NY-REN-21 is asymmetric with respect to DNA binding, positioning SCAND1 to modulate the DNA-binding activity of partner transcription factors rather than to bind DNA directly (PMID:16540086). In prostate cancer cells SCAND1 hetero-oligomerizes with MZF1 and co-occupies chromatin together with heterochromatin protein HP1γ; its overexpression reverses a hybrid epithelial/mesenchymal phenotype toward an epithelial state, suppresses MAP3K-MEK-ERK signaling and proliferation, and inhibits migration and lymph node metastasis in vivo, consistent with a co-repressor role exerted through SCAN-domain partners (PMID:36552758).

1. 2000 High

   Established that SCAND1 is a SCAN-box interaction partner, defining the SCAN domain as a module mediating both homo- and heterodimerization rather than a DNA-binding element.

   Evidence Yeast two-hybrid screen of bone marrow cDNA, reciprocal co-immunoprecipitation, and domain-deletion mapping with MZF1B; in vitro self-association

   PMID:10777584

   Open questions at the time

   • Does not establish a transcriptional output of the SCAND1–MZF1B interaction
   • Functional consequence of self-association unresolved
   • No structural model of the dimerization interface
2. 2002 Medium

   Localized SCAND1 to the nucleus and mapped nuclear targeting to the C-terminal SCAN-related domain, indicating where the protein exerts its interaction function.

   Evidence GFP-fusion live-cell imaging with domain deletions, in vitro transcription/translation, Northern blot and primer extension

   PMID:12383503

   Open questions at the time

   • Diffuse nuclear pattern does not resolve chromatin versus nucleoplasmic distribution
   • No identified nuclear import mechanism
   • Single lab
3. 2006 Medium

   Showed SCAND1 forms an asymmetric DNA-binding-deficient heterodimer with NY-REN-21, providing the biochemical basis for SCAND1 acting as a regulator of partner DNA-binding activity.

   Evidence Yeast two-hybrid, recombinant protein interaction assay, and spectroscopic characterization

   PMID:16540086

   Open questions at the time

   • Effect on NY-REN-21 target gene occupancy not measured
   • Stoichiometry of the heterodimer in cells not determined
   • Single lab, in vitro
4. 2022 Medium

   Connected SCAND1's interaction biochemistry to a cellular phenotype by showing it tethers MZF1 to HP1γ-marked chromatin and represses EMT and proliferation programs in prostate cancer.

   Evidence Overexpression in DU-145 cells, chromatin co-occupancy with HP1γ, EMT-marker western blots, migration assays, and mouse xenograft with IHC

   PMID:36552758

   Open questions at the time

   • Relies on overexpression; endogenous loss-of-function effect not tested
   • Direct target genes of the SCAND1–MZF1–HP1γ complex not mapped
   • Mechanistic link between chromatin co-occupancy and MAP3K-MEK-ERK suppression not resolved

• Whether SCAND1's repressive activity at endogenous loci and its full set of SCAN-zinc finger partners and direct target genes generalize beyond the prostate cancer model remains unknown.
• No genome-wide map of SCAND1-dependent target genes
• No loss-of-function or knockout phenotype in the corpus
• Complete partner repertoire of SCAN-zinc finger factors uncharacterized